Anti-Paraflagellar Rodc Antibodies Inhibit the In-Vitro Growth of Trypanosoma Brucei Brucei

Ambrose Mukisa, Claire Aguttu, George W. Lubega, Joseph Kyambadde, Vincent Pius Alibu, Peter C. Vuzi


Paraflagellar rod (PFR), a conserved structure expressed in all lifecycle stages of the order kinetoplasida except in the amastigotes is vital for the parasites survival. In T.b.brucei, the PFR protein has two major components, PFRc and PFRa with molecular mass 73kDa and 68kDa respectively. Experimental evidences implicate the PFR protein as a highly immunogenic and protective antigen. However, its immunogenic properties underlying its suitability as vaccine candidate has not been adequately investigated in-vitro. This study aimed to demonstrate the growth inhibitory potential of PFR protein against T.b.brucei parasites in–vitro. Antibodies against a recombinant form of the PFRc protein were produced and used to generate immune response. A deoxyribonucleotide (DNA) segment of approximate 672bp encoding the PFRc protein component was amplified using polymerase chain reaction (PCR), cloned and expressed in E.coli (BL21) cells. A 200 µg portion of the purified PFRc protein mixed with 100µl Freund's complete adjuvant (FCA) was used to immunize rabbits. An antibody titre of 2.5 x 104 reciprocal dilutions was obtained following three immunisation boosts, spaced two weeks apart. Western blot analysis showed that rabbit anti-PFRc antibodies recognised specifically a 25kDa protein corresponding to the estimated size of the expressed PFRc protein. 25% of purified anti-rabbit IgG antibodies were able to inhibit ~70% T.b.brucei parasite in vitro.

This confirmed that the PFRc protein is immunogenic in rabbits and can elicit specific growth inhibitory antibodies. However, we recommend invivo studies in humans and domestic animals infected by trypanosomes to ascertain the vaccine potential of this candidate protein for trypanosomiasis.


Anti-Paraflagellar rod c; antibodies; in-vitro growth; Trypanosoma Brucei Brucei.

Full Text:



. Vickerman, K. G., Hide, J. C., Mottram, G. H., (1997). Landmark Landmarks in trypanosome research International, Wallingford, UK., p. 1–38

. Vanhamme, L., Pays, E., McCulloch, R., & Barry, J. D. (2001). An update on antigenic variation in African trypanosomes. Trends Parasitology, 17(7), 338-343.

. Legros, D., Ollivier, G., Gastellu-Etchegorry, M., Paquet .C. & Burri, C. (2002). Treatment of human African trypanosomiasis–present situation and needs for research and development. Lancet Infectious Diseases 2, 437–440.

. Welburn, S. C., &Odiit, M. (2002). Recent developments in human African trypanosomiasis. Current Opinion Infectious Disease, 15(5), 477-484

. Frevert, U., Movila, A., Nikolskaia, O. V., Raper, J., Mackey, Z. B., Abdulla, M., Grab, D. J. (2012). Early invasion of brain parenchyma by African trypanosomes. PLoS One, 7(8).

. Molyneux, D. H., Hopkins, D. R., & Zagaria, N. (2004). Disease eradication elimination and control: the need for accurate and usage. Trends in Parasitology, 20(8), 347-351.

. Olaho-Mukani, W., Munyua, W. K., Njogu, A. R., Mutugi, M. W., & Otsyula, M. (1992).Trypanosomal antigen and antibody levels in field camels following treatment with two trypanocidal drugs. Tropical Medical Parasitology, 43(3), 170-172.

. Matovu, E., Seebeck, T., Enyaru, J. C., &Kaminsky, R. (2001).Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes Infection, 3(9), 763-770

. Pepin, J., & Milord, F. (1994).The treatment of human African trypanosomiasis. Advanced Parasitology, 33, 1-47.

. Borst, P., Bitter, W., Blundell, P. A., Chaves, I., Cross, M., Gerrits, H., Rudenko, G. (1998). Control of VSG gene expression sites in Trypanosoma brucei. Molecular Biochemical Parasitology, 91 (1), 67-76.

. Donelson, J. E., & Rice-ficht, A. C. (1985).Molecular Biology of Trypanosome Antigenic Variation. Microbiology Review, 107-125.

. Pays, & Nolan, D. P. (1998). Expression and function of surface proteins in Trypanosoma brucei. Molecular Biochemical Parasitology, 91(1), 3-36.

. La Greca, F., &Magez, S. (2011). Vaccination against trypanosomiasis, can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist? Human vaccine, 7(11), 1225-1233.

. Abdille, Shao Yang Li, Yonggen Jia, Xun Suo, & .Mkoji. (2007). Evidence for existance of paraflagellar rod 2 (PFR2) gene in Trypanosoma evansi and its conservation among other Kinetoplastid parasites. Experimental parasitology, 188, 614-618.

. Portman, & Gull, K. (2010). The paraflagellar rod of kinetoplastid parasites: from structure to components and function. International Journal of Parasitology, 40(2), 135-148.

. Farina, Attias, M., Souto-padron, T., & W., d. S. (1986).Further studies on the organization of paraxial rod of trypansomatids, Journal of protozoology, 33, 352-557.

. Deflorin, Rudolf M., Seebeck T., Rudolf M., & T., S. (1994). The major components of the paraflagellar rod of Trypanosoma brucei are two similar, but distinct proteins which are encoded by two different gene loci. Journal of Biological Chemistry, 269(46), 28745-28751.

. Broadhead, Dawe, H. R., Farr, H., Griffiths, S., Hart, S. R., Portman, N., Gull, K. (2006). Flagellar motility is required for the viability of the blood stream trypanosome. Nature, 440, 224-227.

. April, K., Clark, E. & Kovtunovych G. (2005). Cloning and expression analysis of two novel paraflagellar rod domain genes found in Trypanosoma cruzi. Parasitology Research, 96(5), 312-320.

. Griffiths, Portman, N., Taylor, P. R., Gordon, S., Ginger, M. L., & Gull, K. (2007). RNA interference mutant induction in vivo demonstrates the essential nature of trypanosome flagellar function during mammalian infection. Eukaryotic Cell, 6(7), 1248-1250.

. Ralston, & Hill (2006). Trypanin a component of the flagellar dynein regulatory complex is essential in the blood stream from African Trypanasomes. PloS pathology 2(9), e101.

. Lubega G.W., Byarugaba D.K., and Prichard R., (2002).Immunisation with a tubulin-rich preparation from T.brucei confers broad protectionagainst African trypanosomiasis. Experimental Parasitology,102 (2), 9-22

. Kroll D., Abdel-Malek, Abdel-Hafiz H., Maercell T., Simpson S., Chen C.Y., Gutierrez-Hartman A. Hoeffler J.P, (1993). Amultifunctional prokaryotic protein expression system: overproduction, affinity purification and selective detection.DNA. Cell Biology, (5), 441-453.

. Li S.Q., Yang W.B., Ma L.J., Xi D.M., Chen Q.L., Song X.W. and Yang L.Z., (2009). Immunization with recombinant actin from Trypanosoma evansi induces protective immunity against T.evansi, T.equiperdum and T. brucei infection. Parasitology research, 104(2) 249-435

. Morell M., Thomas M.C., Caballero T., Alonso C., and Lopez M.C., (2006). The genetic immunization with anti paraflagellar rod protein 2-fused to the HSP70 confer protection against late Trypanasoma cruzi infection. Vaccine 24 (49-50).


  • There are currently no refbacks.




About ASRJETS | Privacy PolicyTerms & Conditions | Contact Us | DisclaimerFAQs 

ASRJETS is published by (GSSRR).